Investigators from Chinese University of Hong Kong Target Chronic Disease (The Association Between an Increased Reimbursement Cap for Chronic Disease Coverage and Healthcare Utilization In China: an Interrupted Time Series Study)

2020 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Daily China News -- Research findings on Disease Attributes - Chronic Disease are discussed in a new report. According to news originating from Hong Kong, People’s Republic of China, by NewsRx correspondents, research stated, “Hypertension and diabetes are highly prevalent in China and pose significant health and economic burdens, but large gaps in care remain for people with such conditions. In this article, drawing on administrative insurance claim data from China’s Urban Employee Basic Medical Insurance (UEBMI), we use an interrupted time series design to examine whether an increase in the monthly reimbursement cap for outpatient visits using chronic disease coverage affects healthcare utilization.”

Financial support for this research came from National Social Science Fund of China.

Our news journalists obtained a quote from the research from the Chinese University of Hong Kong, “The cap was increased by 50 yuan per chronic disease on 1 January 2016, in one of the largest cities in China. Compared with the year before the increase, patients with only hypertension increased their spending using chronic disease coverage by 17.8 yuan (P < 0.001) or 11.6%, and those with only diabetes increased their spending using chronic disease coverage by 19.5 yuan (P < 0.001) or 10.6%, with the differences almost entirely driven by spending on drugs. In addition, these two groups of patients reduced their spending using standard outpatient coverage by 13.9 yuan (P < 0.001) or 5.7% and 14.9 yuan (P = 0.03) or 5.2%, respectively, and thus had no changes in total outpatient spending. Patients with both hypertension and diabetes, meanwhile, increased their spending using chronic disease coverage by 54.8 yuan (P < 0.001) or 18.1% and decreased their spending using standard outpatient coverage by 16.1 yuan (P = 0.002) or 6.1%, with no changes in their probability of hospitalization. Among patients with both hypertension and diabetes who had fewer-than-average outpatient visits in 2015, the hospitalization rate decreased after the 2016 reimbursement cap increase (adjusted odds ratio = 0.702, P = 0.01).”

According to the news editors, the research concluded: “These findings suggest that increasing financial protection for patients with hypertension and diabetes may be an important strategy for reducing adverse health events, such as hospitalization, in China.”

This research has been peer-reviewed.

For more information on this research see: The Association Between an Increased Reimbursement Cap for Chronic Disease Coverage and Healthcare Utilization In China: an Interrupted Time Series Study. Health Policy and Planning, 2020;35(8):1029-1038. Health Policy and Planning can be contacted at: Oxford Univ Press, Great Clarendon St, Oxford OX2 6DP, England. (Oxford University Press - http://www.oup.com/; Health Policy and Planning - heapol.oxfordjournals.org)

The news correspondents report that additional information may be obtained from Yushan Wu, Chinese University of Hong Kong, School for Public Health and Primary Care, Shatin, Hong Kong, People’s Republic of China. Additional authors for this research include Menghan Shen, Wen He and Eng-Kiong Yeoh.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1093/heapol/czaa087. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)